Evidence map›Paper›PMID 33793554›Full record

ArticlePLoS medicine2021

Epidemiological, clinical, and public health response characteristics of a large outbreak of diphtheria among the Rohingya population in Cox's Bazar, Bangladesh, 2017 to 2019: A retrospective study.

Jonathan A Polonsky, Melissa Ivey, Md Khadimul Anam Mazhar, Ziaur Rahman, Olivier le Polain de Waroux, Basel Karo, Katri Jalava, Sirenda Vong, Amrish Baidjoe, Janet Diaz and 11 more

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 13 institutions in 7 countries.

Jonathan A PolonskyWorld Health Organization, Geneva, Switzerland.ORCID 0000-0002-8634-4255
Melissa IveyMédecins Sans Frontières, Amsterdam, the Netherlands.ORCID 0000-0002-1795-5108
Md Khadimul Anam MazharWorld Health Organization Country Office for Bangladesh, Dhaka, Bangladesh.ORCID 0000-0002-9303-6541
Ziaur RahmanMinistry of Health and Family Welfare, Dhaka, Bangladesh.ORCID 0000-0002-7726-7120
Olivier le Polain de WarouxWorld Health Organization, Geneva, Switzerland.ORCID 0000-0003-3458-2945
Basel KaroGlobal Outbreak Alert and Response Network (GOARN), Geneva, Switzerland.ORCID 0000-0003-2178-1654
Katri JalavaWorld Health Organization Country Office for Bangladesh, Dhaka, Bangladesh.ORCID 0000-0001-9106-3186
Sirenda VongWorld Health Organization South-East Asia Regional Office, New Delhi, India.
Amrish BaidjoeLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Janet DiazWorld Health Organization, Geneva, Switzerland.ORCID 0000-0002-8753-531X
Flavio FingerGlobal Outbreak Alert and Response Network (GOARN), Geneva, Switzerland.ORCID 0000-0002-8613-5170
Zakir H HabibInstitute of Epidemiology Disease Control and Research (IEDCR), Dhaka, Bangladesh.
Charls Erik HalderInternational Organization for Migration, Cox's Bazar, Bangladesh.
Christopher HaskewWorld Health Organization, Geneva, Switzerland.ORCID 0000-0003-1992-808X
Laurent KaiserInstitute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Ali S KhanGlobal Outbreak Alert and Response Network (GOARN), Geneva, Switzerland.ORCID 0000-0001-8161-2823
Lucky SangalWorld Health Organization Country Office for India, New Delhi, India.
Tahmina ShirinInstitute of Epidemiology Disease Control and Research (IEDCR), Dhaka, Bangladesh.
Quazi Ahmed ZakiInstitute of Epidemiology Disease Control and Research (IEDCR), Dhaka, Bangladesh.ORCID 0000-0002-2884-5676
Md Abdus SalamMinistry of Health and Family Welfare, Dhaka, Bangladesh.
Kate WhiteMédecins Sans Frontières, Amsterdam, the Netherlands.
Institute of Epidemiology, Disease Control and Research · BDLondon School of Hygiene & Tropical Medicine · GBMédecins Sans Frontières · NLMinistry of Health and Family Welfare · BDUniversity of Geneva · CHWorld Health Organization · CHWorld University of Bangladesh · BDInternational Organization for Migration · CHNebraska Medical Center · USPublic Health England · GBRobert Koch Institute · DEWorld Health Organization - India · INWorld Health Organization Regional Office for South-East Asia · IN

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundUnrest in Myanmar in August 2017 resulted in the movement of over 700,000 Rohingya refugees to overcrowded camps in Cox's Bazar, Bangladesh. A large outbreak of diphtheria subsequently began in this population. METHODS AND

findingsData were collected during mass vaccination campaigns (MVCs), contact tracing activities, and from 9 Diphtheria Treatment Centers (DTCs) operated by national and international organizations. These data were used to describe the epidemiological and clinical features and the control measures to prevent transmission, during the first 2 years of the outbreak. Between November 10, 2017 and November 9, 2019, 7,064 cases were reported: 285 (4.0%) laboratory-confirmed, 3,610 (51.1%) probable, and 3,169 (44.9%) suspected cases. The crude attack rate was 51.5 cases per 10,000 person-years, and epidemic doubling time was 4.4 days (95% confidence interval [CI] 4.2-4.7) during the exponential growth phase. The median age was 10 years (range 0-85), and 3,126 (44.3%) were male. The typical symptoms were sore throat (93.5%), fever (86.0%), pseudomembrane (34.7%), and gross cervical lymphadenopathy (GCL; 30.6%). Diphtheria antitoxin (DAT) was administered to 1,062 (89.0%) out of 1,193 eligible patients, with adverse reactions following among 229 (21.6%). There were 45 deaths (case fatality ratio [CFR] 0.6%). Household contacts for 5,702 (80.7%) of 7,064 cases were successfully traced. A total of 41,452 contacts were identified, of whom 40,364 (97.4%) consented to begin chemoprophylaxis; adherence was 55.0% (N = 22,218) at 3-day follow-up. Unvaccinated household contacts were vaccinated with 3 doses (with 4-week interval), while a booster dose was administered if the primary vaccination schedule had been completed. The proportion of contacts vaccinated was 64.7% overall. Three MVC rounds were conducted, with administrative coverage varying between 88.5% and 110.4%. Pentavalent vaccine was administered to those aged 6 weeks to 6 years, while tetanus and diphtheria (Td) vaccine was administered to those aged 7 years and older. Lack of adequate diagnostic capacity to confirm cases was the main limitation, with a majority of cases unconfirmed and the proportion of true diphtheria cases unknown.

conclusionsTo our knowledge, this is the largest reported diphtheria outbreak in refugee settings. We observed that high population density, poor living conditions, and fast growth rate were associated with explosive expansion of the outbreak during the initial exponential growth phase. Three rounds of mass vaccinations targeting those aged 6 weeks to 14 years were associated with only modestly reduced transmission, and additional public health measures were necessary to end the outbreak. This outbreak has a long-lasting tail, with Rt oscillating at around 1 for an extended period. An adequate global DAT stockpile needs to be maintained. All populations must have access to health services and routine vaccination, and this access must be maintained during humanitarian crises.

Indexed as

Public HealthAdolescentAdultAgedAged, 80 and overBangladeshChildChild, PreschoolDiphtheriaDisease OutbreaksHumansInfantInfant, NewbornMaleMiddle AgedRefugee Camps

Identifiers

PMID33793554
PMCPMC8059831
OpenAlexW3151115352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.